Raymond James raises Charles Schwab stock price target on outlook By Investing.com

Raymond James raised its Charles Schwab price target to $137 from $126 and maintained an Outperform rating after the company’s 2026 investor day. The firm cited strong competitive positioning, healthy core growth, attractive EPS growth, and a modest valuation at 12x 2027 EPS, while InvestingPro data shows 11 analysts have recently raised earnings estimates and fiscal 2026 consensus EPS of $6.02. Schwab also reported $7.2 billion in April core net new assets and $12.61 trillion in client assets, alongside new AI initiatives for wealth management and retail portfolio insights.

Analysis

SCHW is becoming a cleaner “quality compounder” trade because the market is still anchoring on the wrong debate. The more durable driver is not AI adoption per se, but that AI lowers servicing cost per client while broadening the addressable mass-affluent base, which should lift operating leverage and justify a higher multiple if asset gathering stays steady.

The second-order positive is that stronger estimate revisions can feed directly into valuation expansion: with the stock still priced like a mature financial, even modest upward EPS drift can compress the perceived discount to peers. That creates a reflexive setup where each incremental asset inflow or productivity update reduces the “AI skepticism” overhang and forces systematic and discretionary investors to re-rate the name.

The main risk is competitive intensity in wealth/retail brokerage, especially if larger wirehouse platforms and trading-oriented incumbents use fee compression or crypto access to defend share. The bull case is more fragile over the next 1-2 quarters than the 1-2 year horizon: if market beta weakens and client cash balances migrate out faster than advisor productivity improves, the stock can stall despite good operating headlines.

Contrarian view: the consensus may be underestimating how much of SCHW’s upside is already embedded in the revised earnings path, while overestimating the speed at which AI monetizes. That argues for owning SCHW as a relative-quality name, but not as an unconstrained outright momentum chase unless there is follow-through in net new assets and a continued string of estimate revisions.

Key Decisions for Investors

• Long SCHW vs. MS as a pair trade over the next 3-6 months: SCHW has the more visible self-help/estimate-revision path, while MS faces a more direct competitive overhang in client acquisition and trading economics.
• Buy SCHW on 2-4 week pullbacks, targeting a 10-15% upside move if the next round of revisions confirms the investor-day cadence; use a tight stop if estimate momentum fades.
• For cleaner convexity, consider SCHW Jan-2027 calls struck near current spot-to-10% OTM: the risk/reward is attractive if the market starts capitalizing the higher EPS runway at a richer multiple.
• Short-dated downside hedge: buy SCHW puts around the next monthly asset-flow print if you are long the stock, since the name is most vulnerable to any disappointment in net new assets or cash sorting.
• Avoid chasing MS on the same headline; use it as the hedge leg until fee compression and crypto competition prove transitory rather than a real share-loss problem.